• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.

作者信息

Psomas Christina, Lavigne Jean-Philippe, Barbuat Claudine, Trabelsi Selma, Ghosn Jade, Lascoux-Combe Caroline, Flandre Philippe, Cuzin Lise, Reynes Jacques, Autran Brigitte, Corbeau Pierre

机构信息

Infectious Diseases Department, University Hospital, Montpellier, Montpellier, France.

出版信息

Blood. 2013 Sep 26;122(13):2282-3. doi: 10.1182/blood-2013-06-507012.

DOI:10.1182/blood-2013-06-507012
PMID:24072848
Abstract
摘要

相似文献

1
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.马拉维若引起的循环细菌产物减少与HIV感染者免疫激活增加无关。
Blood. 2013 Sep 26;122(13):2282-3. doi: 10.1182/blood-2013-06-507012.
2
Response: Maraviroc intensification and microbial translocation.反应：马拉维若强化治疗与微生物易位
Blood. 2013 Sep 26;122(13):2283-4. doi: 10.1182/blood-2013-08-516930.
3
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.马拉维若强化治疗对治疗后 HIV 感染个体中 CD4+T 细胞恢复不完全者的免疫效应：一项随机试验。
Blood. 2013 Jun 6;121(23):4635-46. doi: 10.1182/blood-2012-06-436345. Epub 2013 Apr 15.
4
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.在CD4+ T细胞恢复欠佳的个体中，将马拉维若添加至抗逆转录病毒抑制疗法的病毒学和免疫学效应
AIDS. 2015 Oct 23;29(16):2121-9. doi: 10.1097/QAD.0000000000000810.
5
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells.用CCR5拮抗剂马拉维若治疗HIV-1感染个体后，调节性T细胞频率降低和激活与病毒载量降低相关，而非药物对调节性T细胞的直接作用。
Viral Immunol. 2016 Apr;29(3):192-6. doi: 10.1089/vim.2015.0046. Epub 2016 Jan 26.
6
Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia.改用马拉维若/雷特格韦联合疗法会导致免疫状况不佳且伴有低水平的HIV病毒血症。
AIDS. 2015 Apr 24;29(7):853-6. doi: 10.1097/QAD.0000000000000626.
7
Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals.马拉维若与依非韦伦联合齐多夫定/拉米夫定治疗对初治 HIV 感染者 CD4/CD8 比值的影响。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01763-17. Print 2017 Dec.
8
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.含马拉维若方案在常规临床实践中病毒学失败的HIV-1感染个体中的耐用性和有效性
PLoS One. 2015 Dec 29;10(12):e0144746. doi: 10.1371/journal.pone.0144746. eCollection 2015.
9
T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.短期接触马拉维若后 HIV 感染患者 T 细胞的变化与抗病毒活性有关。
J Infect. 2012 Apr;64(4):417-23. doi: 10.1016/j.jinf.2011.12.017. Epub 2011 Dec 29.
10
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc.在一个接受马拉维若的有抗逆转录病毒治疗经验的HIV-1感染患者的回顾性、多中心、观察性队列研究中，药物的有效性、安全性、耐用性及免疫恢复情况
Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

引用本文的文献

1
Identification of distinct immune activation profiles in adult humans.鉴定成年人类中不同的免疫激活特征。
Sci Rep. 2020 Nov 30;10(1):20824. doi: 10.1038/s41598-020-77707-6.
2
Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.微生物易位与 HIV-1 感染并病毒血症得到抑制的成年人中特定的免疫激活特征相关联。
Front Immunol. 2019 Sep 13;10:2185. doi: 10.3389/fimmu.2019.02185. eCollection 2019.
3
Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
微生物易位与HIV-HCV合并感染患者的HIV进化相关。
PLoS One. 2017 Sep 21;12(9):e0183372. doi: 10.1371/journal.pone.0183372. eCollection 2017.
4
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.马拉维若强化治疗对免疫恢复欠佳的抗逆转录病毒治疗患者的疗效：一项为期48周的安慰剂对照随机试验。
PLoS One. 2015 Jul 24;10(7):e0132430. doi: 10.1371/journal.pone.0132430. eCollection 2015.
5
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).使用马拉维若（CCR5拮抗剂）强化治疗可使接受cART治疗的慢性HIV感染受试者中表达CD16的单核细胞数量减少，并与神经认知测试表现的改善相关：对HIV相关神经认知疾病（HAND）的意义。
J Neurovirol. 2014 Dec;20(6):571-82. doi: 10.1007/s13365-014-0279-x. Epub 2014 Sep 17.
6
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?HIV 和艾滋病自然控制期间的免疫反应：治愈的希望在哪里？
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130436. doi: 10.1098/rstb.2013.0436. Print 2014.